The valuation growth of VR LIFE, strong clinical traction, and the upcoming entry into the US market are strengthening the strategy of H2 Global Group. Furthermore, the innovative platform, which… Military and emergency services in focus: European MedTech innovation with Japanese roots sends a strong signal to investors and partners.

H2 Global Group is strengthening its position as a European technology group connecting capital with clinically validated healthcare innovations. A prime example is VR LIFE and its flagship MDR-certified medical… Strong Signal for Investors: VR LIFE and H2 Global Group Validate the Value of European MedTech Innovation

A Strong Signal for Investors: VR LIFE and H2 Global Group Confirm the Value of Czech Innovations in MedTech Czech MedTech is no longer a fringe topic and is beginning… A Strong Signal for Investors: VR LIFE and H2 Global Group Confirm the Value of Czech MedTech Innovations

The world has entered a period of turbulence. Geopolitical and trade instability, pressure on healthcare systems, and an aging population are changing the rules of the game. Investors are no… Where Are the Best Investment Prospects in Times of Turbulent Uncertainty? Smart Capital is Targeting the Medicine of the Future.

Olympic champion and entrepreneur Aleš Valenta was a guest on Radek Erben’s podcast, where he candidly described his journey from elite sports to entrepreneurship in healthcare innovation. In the interview,… Aleš Valenta: From Olympic Gold to a Hydrogen Investment Opportunity

Czech start-ups are experiencing a significant investment boom, with an increasing share of capital flowing into medical projects. Investors are looking for technologies with global potential, strong intellectual property, clinical… Investment boom in Czech MedTech: H2 Global Group, with a Japanese patent and a pre-money valuation of CZK 1.6 billion, opens the door to investors

Forgetting your keys or an acquaintance’s name from time to time is human. However, if memory lapses occur more frequently, worsen, and begin to affect your daily life, it might… Do you forget things often? Did you know it could be a precursor to Alzheimer’s dementia?

It is a test for families, caregivers, healthcare and social systems – and above all for our ability to deal with vulnerability and aging with dignity. Facts that cannot be… Dementia is not just “one person’s diagnosis.”

In this episode, Prof. Shigeo Ohta and David Maršálek, founder of H2 Global Group, return to the beginning of their “hydrogen” journey. Ohta describes how his academic research gradually led… Molecular Hydrogen Not Only Against Alzheimer’s Dementia — The Medicine of the Future

Just a few years ago, investments in healthcare and medical innovation were mainly opportunities for large funds, strategic players, and a narrow group of specialized investors. Today, the situation is… Czechs Have a More Open Path to Investing in the “Medicine of the Future.” Why Capital Is Moving into MedTech, HealthTech, Mental Health, and Longevity

A global problem without a simple solution Dementia and neurodegenerative diseases are among the greatest challenges of modern medicine today. They affect tens of millions of people worldwide, and their… Molecular Hydrogen on the Path to Modern Medicine

Today in Ostrava, the clinical evaluation of the device was officially launched as part of a clinical study aimed at demonstrating the safety of non-invasive inhalation of molecular hydrogen in… The clinical study has been launched

PharmDr. Milan Krajíček is a pharmacist and entrepreneur who has spent his entire life combining rigorous expertise, regulatory discipline, and the ability to turn ideas into practice—with a single goal:… Science That Makes Sense: Molecular Hydrogen as an Investment in Health and the Future

When I look back today, I see more than 21 years of life devoted to a single idea.The idea that even the smallest element in the universe can have a… Japanese Professor Shigeo Ohta on Alzheimer’s Dementia: Why We Do What We Do – They Wrote About Us as Well

On Friday, we welcomed Professor Shigeo Ohta to the Czech Republic — a world-renowned authority in the field of molecular hydrogen and co-founder of H2 Global Group. Together with Czech experts, we are… Authority in the Field of Molecular Hydrogen

Dementia and Alzheimer’s disease are rapidly becoming one of the biggest health, social, and economic topics of the present, and especially of the coming decades. Alzheimer’s dementia is often referred… Alzheimer’s Dementia and Longevity: H2 Global Group Offers a Solution, Opens an Investment Window, and Targets the Medicine of the Future

The longevity market is undergoing a global boom. More and more people are realizing the immense possibilities of today’s modern world, and the desire to live to an old age—while… “Forever Young”: H2 Global Group Brings a Hydrogen Standard to the Field of Longevity

Alzheimer’s dementia ranks among the greatest challenges, and not just for an aging society. It can strike any of us at any time—directly, within the family, or in our close… Alzheimer’s Dementia: Breakthrough Czech Patient-Friendly Solution Turns Problem into Opportunity. And Investors Don’t Want to Miss Out

According to the World Health Organization (WHO), depression, anxiety, and other mental health issues cost the global economy approximately 12 billion working days per year, representing a loss of around… Molecular Hydrogen Has Entered the Corporate World. HR Specialist Describes How It Can Support Employee Health, Performance, and Save Companies Money